1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
65C4ACD038331B11985256DBB0061478E
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-incorporating-biomarker-research-for-rd-success?opendocument
18
19
20
21
22
23
24/bestp/domrep.nsf
25DB




Products & Services Business Operations Alliances and Partnerships Relationship Management

Incorporating Biomarker Research for R&D Success

ID: 4484


Features:

Metrics, Graphics


Pages/Slides: 31


Published: Pre-2013


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
NonMembers: To download a complimentary excerpt of this study, please click here.


More and more pharmaceutical and diagnostic companies are exploring the possible applications for biomarkers. Such a mammoth task requires that the biomarker research function be in a company where it is well-organized, empowered, appropriately staffed and resourced and impacted by scientists' and other employees' creativity and innovation. This 30-page report surveys the current landscape of biomarker research at eight pharmaceutical companies and one reference laboratory. Senior R&D executives comment on how the area of biomarker research is and should be structured, organized and used most effectively to propel diagnostics and therapy forward. Metrics discussed include: Degree of Centralization; Size of Biomarker Group; Organization of Work by Project Team; Therapy Area and Function; Degree of Outsourcing; Degree of Impact of Biomarker Research on Drug Development and Methods of Sample Collection Used and Degree of Standardization. This research originated with the Best Practices, LLC Business Excellence Board (BEB).


Industries Profiled:
Pharmaceutical; Manufacturing; Biotech; Consumer Products; Diagnostic; Medical Device; Health Care


Companies Profiled:
AstraZeneca; Bayer; Bristol-Myers Squibb; Eli Lilly; Focus Technologies; GlaxoSmithKline; Novartis; Pfizer; Roche


If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.